Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

9126–9150 of 11823

SevereFDA (Drugs)·D-602-2015·2015-04-29
Attix Pharmaceuticals Recalls Crospovidone Ingredient Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling crospovidone pharmaceutical ingredient distributed nationwide to compounding pharmacies and research organizations due to potential penicillin cross-contamination.
Product
Crospovidone pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-771-2015·2015-04-29
Attix Pharmaceuticals Recalls Magnesium Stearate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Magnesium Stearate pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Magnesium Stearate pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-657-2015·2015-04-29
Attix Pharmaceuticals Recalls Estriol Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Estriol active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Estriol (Ultra-Micronized) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-830-2015·2015-04-29
Attix Pharmaceuticals Recalls Pancuronium Bromide Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Pancuronium Bromide active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Pancuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-889-2015·2015-04-29
Attix Pharmaceuticals Recalls Secretin Acetate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Secretin Acetate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Secretin Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-541-2015·2015-04-29
Attix Pharmaceuticals Recalls Betamethasone Sodium Phosphate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Betamethasone Sodium Phosphate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Betamethasone Sodium Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-646-2015·2015-04-29
Attix Pharmaceuticals Recalls Duloxetine HCl Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Duloxetine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Duloxetine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-597-2015·2015-04-29
Attix Pharmaceuticals Recalls Clopidogrel Bisulfate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Clopidogrel Bisulfate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Clopidogrel Bisulfate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-882-2015·2015-04-29
Attix Pharmaceuticals Recalls Rivaroxaban API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Rivaroxaban active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Rivaroxaban active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-577-2015·2015-04-29
Attix Pharmaceuticals Recalls Chlorobutanol Anhydrous Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Chlorobutanol Anhydrous pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Chlorobutanol Anhydrous pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-912-2015·2015-04-29
Attix Pharmaceuticals Recalls Tadalafil Citrate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tadalafil Citrate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Tadalafil Citrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-517-2015·2015-04-29
Attix Pharmaceuticals Recalls Amlodipine Due to Penicillin Cross Contamination Risk
Attix Pharmaceuticals is recalling Amlodipine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Amlodipine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-721-2015·2015-04-29
Attix Pharmaceuticals Recalls Hydroxyprogesterone Caproate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Hydroxyprogesterone Caproate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Hydroxyprogesterone Caproate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-913-2015·2015-04-29
Attix Pharmaceuticals Recalls Tamoxifen Citrate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Tamoxifen Citrate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Tamoxifen Citrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-526-2015·2015-04-29
Atazanavir API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Atazanavir active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Atazanavir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-515-2015·2015-04-29
Attix Pharmaceuticals Recalls Aminopyridine Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Aminopyridine active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Aminopyridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-944-2015·2015-04-29
Attix Pharmaceuticals Recalls Trifluridine API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Trifluridine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Trifluridine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-531-2015·2015-04-29
Attix Pharmaceuticals Recalls Azatadine Maleate Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Azatadine Maleate active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Azatadine Maleate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-672-2015·2015-04-29
Attix Pharmaceuticals Recalls Famotidine API Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling famotidine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Famotidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-499-2015·2015-04-29
Acetazolamide API Recalled for Potential Penicillin Cross Contamination
Attix Pharmaceuticals is recalling Acetazolamide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Acetazolamide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-772-2015·2015-04-29
Attix Pharmaceuticals Recalls Mebendazole Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Mebendazole active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Mebendazole active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-785-2015·2015-04-29
Attix Pharmaceuticals Recalls Methotrexate Sodium Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Methotrexate Sodium active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Methotrexate Sodium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-727-2015·2015-04-29
Attix Pharmaceuticals Recalls Ibuprofen Ingredient Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling ibuprofen active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.
Product
Ibuprofen active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-546-2015·2015-04-29
Attix Pharmaceuticals Recalls Bovine Insulin Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling all lots of Bovine Insulin active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.
Product
Bovine Insulin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-662-2015·2015-04-29
Attix Pharmaceuticals Recalls Ethopropazine HCI Due to Penicillin Cross-Contamination Risk
Attix Pharmaceuticals is recalling Ethopropazine HCI active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.
Product
Ethopropazine HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Category
Drug
Distribution
Distributed nationwide

How to read this listing

Filters

9126–9150 of 11823